329 related articles for article (PubMed ID: 27242800)
1. Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.
Sridhar S
Front Immunol; 2016; 7():195. PubMed ID: 27242800
[TBL] [Abstract][Full Text] [Related]
2. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
3. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection.
Kwon JS; Yoon J; Kim YJ; Kang K; Woo S; Jung DI; Song MK; Kim EH; Kwon HI; Choi YK; Kim J; Lee J; Yoon Y; Shin EC; Youn JW
Eur J Immunol; 2014 Aug; 44(8):2360-9. PubMed ID: 24825439
[TBL] [Abstract][Full Text] [Related]
6. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
Krammer F
Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
[TBL] [Abstract][Full Text] [Related]
7. Pandemic preparedness: toward a universal influenza vaccine.
Roose K; Fiers W; Saelens X
Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K
J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral vectors as novel vaccines for influenza.
Coughlan L; Mullarkey C; Gilbert S
J Pharm Pharmacol; 2015 Mar; 67(3):382-99. PubMed ID: 25560474
[TBL] [Abstract][Full Text] [Related]
10. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells.
Vogel AJ; Brown DM
Front Immunol; 2015; 6():327. PubMed ID: 26161083
[TBL] [Abstract][Full Text] [Related]
11. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
12. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Kreijtz JH; Bodewes R; van den Brand JM; de Mutsert G; Baas C; van Amerongen G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2009 Aug; 27(36):4983-9. PubMed ID: 19538996
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
[TBL] [Abstract][Full Text] [Related]
14. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
15. Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.
Carascal MB; Pavon RDN; Rivera WL
Front Immunol; 2022; 13():878943. PubMed ID: 35663997
[TBL] [Abstract][Full Text] [Related]
16. Pediatric influenza vaccination: understanding the T-cell response.
Bodewes R; Fraaij PL; Osterhaus AD; Rimmelzwaan GF
Expert Rev Vaccines; 2012 Aug; 11(8):963-71. PubMed ID: 23002977
[TBL] [Abstract][Full Text] [Related]
17. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
18. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.
Liu J; Wu B; Zhang S; Tan S; Sun Y; Chen Z; Qin Y; Sun M; Shi G; Wu Y; Sun M; Liu N; Ning K; Ma Y; Gao B; Yan J; Zhu F; Wang H; Gao GF
Eur J Immunol; 2013 Aug; 43(8):2055-69. PubMed ID: 23681926
[TBL] [Abstract][Full Text] [Related]
19. Strategies towards universal pandemic influenza vaccines.
He F; Leyrer S; Kwang J
Expert Rev Vaccines; 2016; 15(2):215-25. PubMed ID: 26641724
[TBL] [Abstract][Full Text] [Related]
20. Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses.
Jang YH; Seong BL
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33916924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]